SURVIVAL AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR TYROSINE KINASE INHIBITORS (TKI) IN CHILDREN WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE; A SINGLE INSTITUTION EXPERIENCE
PEDIATRIC BLOOD & CANCER（2012）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要